홈헬스케어 시장 예측(-2030년) : 컴포넌트별, 적응증별, 유통 채널별, 지역별 세계 분석

According to Stratistics MRC, the Global Home Healthcare Market is accounted for $324.72 billion in 2024 and is expected to reach $661.81 billion by 2030 growing at a CAGR of 12.6% during the forecast period. A broad spectrum of medical and non-medical services offered in a patient's home with the goal of promoting, maintaining, or restoring health is collectively referred to as home healthcare. These services, which can include medical care, physical therapy, and help with everyday tasks like dressing, eating, and bathing, are usually provided by healthcare professionals like nurses, therapists, and assistants. Moreover, with home healthcare, patients can receive individualized attention and support in the comfort of their own homes, providing a convenient and comfortable substitute for hospital or nursing home care.

According to the National Association for Home Care & Hospice (NAHC), home healthcare is a vital service that supports the independence and quality of life for millions of Americans by providing necessary medical care and support services in the comfort of their homes.

Market Dynamics:

Driver:

Reduced hospitalization time

There is an increasing need for home rehabilitation and post-acute care services as hospitals are releasing patients earlier in order to control bed capacity and lower healthcare costs. By offering specialized nursing care, rehabilitation therapies, and medical monitoring to patients in their homes, home healthcare promotes continuity of care. Additionally, this method improves recovery outcomes, lowers the chance of readmissions to the hospital, and supports patient-centered care models that prioritize each patient's unique rehabilitation needs and recovery goals.

Restraint:

Shortages in the workforce

There is a severe scarcity of workers in the home healthcare industry, making it difficult to find and keep skilled healthcare workers. Professionals with expertise in home healthcare services, such as therapists, home health aides, and nurses, are in great demand; however, they may be hard to find in some places or face competitive employment markets. Furthermore, a number of factors, such as changing demographics, an aging healthcare workforce, job burnout, and difficulties providing competitive pay and benefits, are causing a shortage of workers.

Opportunity:

Development of management programs for chronic illnesses

There is a chance to grow chronic disease management programs in the home healthcare industry because chronic diseases like diabetes, heart problems, and respiratory disorders are becoming more common. In order to help people with chronic conditions better manage their health and stop the progression of their disease, home healthcare providers can make use of patient education programs, remote monitoring technologies, and personalized care plans. Moreover, providers can meet the increasing demand for individualized long-term care solutions by providing complete disease management and rehabilitation services at home.

Threat:

Pressures from competition and market consolidation

Competitive pressures and market consolidation present threats to smaller or independent home healthcare providers. Larger healthcare organizations, including hospital systems and integrated delivery networks, may leverage economies of scale, technological resources, and established referral networks to dominate the home healthcare market. Additionally, competitive bidding processes and contracting requirements imposed by insurers and government agencies can create barriers to entry for smaller providers, limiting their ability to compete effectively and maintain market share.

Covid-19 Impact:

The COVID-19 pandemic has had a profound impact on the home healthcare market, accelerating its growth and evolution. As healthcare systems worldwide faced unprecedented challenges in managing patient surges and minimizing virus transmission risks, there was a notable shift towards home-based care models. Home healthcare services became essential for delivering non-urgent medical care, monitoring COVID-19 patients in isolation, and supporting individuals recovering from the virus. Furthermore, telehealth and remote monitoring technologies saw rapid adoption to facilitate virtual consultations and disease management, ensuring continuity of care while minimizing exposure risks.

The Cardiovascular Disorder and Hypertension segment is expected to be the largest during the forecast period

The cardiovascular diseases and hypertension segment is expected to hold the largest share of the home healthcare market because of their prevalence and the need for ongoing management outside of traditional hospital settings. Services like blood pressure monitoring, medication administration and lifestyle counseling are included in this category to help manage cardiovascular health. Moreover, the need for home healthcare services catered to these particular needs is rising due to the aging population and the rising incidence of cardiovascular diseases worldwide.

The Retail Sales segment is expected to have the highest CAGR during the forecast period

The retail sales segment in the home healthcare market has shown the highest CAGR, reflecting a significant shift towards consumer-centric healthcare solutions. This segment encompasses the direct sale of medical products and devices to individuals through various retail channels, including pharmacies, online platforms, and specialty stores. Additionally, a number of factors, including an aging population that is increasingly choosing home-based care, retail channels' accessibility and convenience, and rising acceptance of self-care solutions, are contributing to the industry's rapid growth.

Region with largest share:

Due to a rapidly aging population, high healthcare costs, and sophisticated healthcare infrastructure, North America currently holds the largest share of the home healthcare market. Robust investments in home healthcare technologies and services, advantageous reimbursement policies, and strong consumer demand for individualized care solutions all serve to highlight the region's leadership. Furthermore, rising rates of chronic illness and a move toward more affordable healthcare options support the market's expansion. It is anticipated that North America will maintain its position as a leader in home healthcare thanks to constant innovations and initiatives aimed at improving the quality and accessibility of care in home environments.

Region with highest CAGR:

The home healthcare market is growing significantly in the European region, which has the highest CAGR. Numerous factors, such as an aging population, rising healthcare costs, and a move toward patient-centric care models, are responsible for this growth. In order to meet the growing demand for individualized healthcare solutions and to lower hospital admission rates, European nations are investing an increasing amount of money in home healthcare services and infrastructure. Additionally, the region's market is expanding due to supportive government policies, reimbursement structures that encourage home-based care, and the uptake of cutting-edge medical technologies.

Key players in the market

Some of the key players in Home Healthcare market include Johnson & Johnson Services, Inc., Medline Industries, Inc, GE Healthcare, Koninklijke Phillips NV., Bayer HealthCare, 3M Healthcare, Omron Healthcare, Inc., Linde Healthcare, B. Braun Melsungen AG, F.Hoffmann-La Roche, Ltd., Genesis Healthcare, Inc., Medtronic PLC, Teleflex, Inc., Abbott and Cardinal Health Inc.

Key Developments:

In May 2024, Medline announced a new prime vendor partnership with Urology, P.C. - a leading provider of urological services and surgical procedures based in Lincoln, Nebraska. Urology, P.C. operates a state-of-the-art combined medical practice, oncology clinic and surgery center -- Urology Surgical Center -- in Lincoln and provides services in 18 satellite clinics around the state.

In April 2024, Bayer AG has entered into a long-term supply agreement for renewable energy with Wuppertaler Stadtwerke (WSW), the public utility company of Wuppertal in North Rhein-Westphalia, Germany. Under the agreement, WSW will provide Bayer with over 120 GWh of wind and/or solar power from German wind and solar parks annually, equivalent to the electricity consumption of approximately 30,000 households.

In December 2023, GE Healthcare has entered into a distribution agreement with mobile-first clinical surveillance technology provider, AirStrip to expand AirStrip Cardiology and Patient Monitoring solutions in the US. The mobile application from AirStrip enables clinicians to view clinical data on the web and on mobile devices. It connects with cardiac rhythm strips and 12-lead ECGs, allowing clinicians to monitor numerous patients at the same time and can receive STEMI notifications.

Components Covered:

• Equipment
• Service
• Other Components

Indications Covered:

• Cardiovascular Disorder and Hypertension
• Diabetes and Kidney Disorders
• Neurological and Mental Disorders
• Respiratory Disease and COPD
• Maternal Disorders
• Mobility Disorders
• Cancer
• Wound Care
• Other Indications

Distribution Channels Covered:

• Direct Tenders
• Retail Sales

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Emerging Markets
• 3.7 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Home Healthcare Market, By Component

• 5.1 Introduction
• 5.2 Equipment
  • 5.2.1 Therapeutic
    • 5.2.1.1 Home IV Pumps
    • 5.2.1.2 Home Dialysis Equipment
    • 5.2.1.3 Insulin Delivery Devices
    • 5.2.1.4 Home Respiratory Therapy Equipment
    • 5.2.1.5 Other Therapeutics
  • 5.2.2 Diagnostic
    • 5.2.2.1 Heart Rate Monitors
    • 5.2.2.2 Multi Para Diagnostic Monitors
    • 5.2.2.3 Diabetic Care Unit
    • 5.2.2.4 Apnea and Sleep Monitors
    • 5.2.2.5 BP Monitors
    • 5.2.2.6 Holter Monitors
    • 5.2.2.7 Home Pregnancy and Fertility Kits
    • 5.2.2.8 Other Diagnostics
  • 5.2.3 Mobility Care
    • 5.2.3.1 Wheelchair
    • 5.2.3.2 Walking Assist Devices
    • 5.2.3.3 Home Medical Furniture
• 5.3 Service
  • 5.3.1 Skilled Nursing
  • 5.3.2 Rehabilitation Therapy
  • 5.3.3 Hospice & Palliative Care
  • 5.3.4 Unskilled Care
  • 5.3.5 Respiratory Therapy
  • 5.3.6 Infusion Therapy
  • 5.3.7 Pregnancy Care
  • 5.3.8 Other Services
• 5.4 Other Components

6 Global Home Healthcare Market, By Indication

• 6.1 Introduction
• 6.2 Cardiovascular Disorder and Hypertension
• 6.3 Diabetes and Kidney Disorders
• 6.4 Neurological and Mental Disorders
• 6.5 Respiratory Disease and COPD
• 6.6 Maternal Disorders
• 6.7 Mobility Disorders
• 6.8 Cancer
• 6.9 Wound Care
• 6.10 Other Indications

7 Global Home Healthcare Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Direct Tenders
• 7.3 Retail Sales

8 Global Home Healthcare Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Johnson & Johnson Services, Inc.
• 10.2 Medline Industries, Inc
• 10.3 GE Healthcare
• 10.4 Koninklijke Phillips NV.
• 10.5 Bayer HealthCare
• 10.6 3M Healthcare
• 10.7 Omron Healthcare, Inc.
• 10.8 Linde Healthcare
• 10.9 B. Braun Melsungen AG
• 10.10 F.Hoffmann-La Roche, Ltd.
• 10.11 Genesis Healthcare, Inc.
• 10.12 Medtronic PLC
• 10.13 Teleflex, Inc.
• 10.14 Abbott
• 10.15 Cardinal Health Inc.